Description
Description
Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of Voriconazole in the Chinese market, of which Pfizer has the largest market share.
According to CRI analysis, the sales of Voriconazole have grown steadily from 2016 to 2019. In 2020, its sales fell by 20.41%, from CNY1.888 billion in 2019 to CNY1.503 billion in 2020. The main reason is that the Covid-19 epidemic has affected the hospital’s overall diagnosis and treatment business, resulting in a decline in its sales. The CAGR of Voriconazole in the Chinese market from 2016 to 2020 is 2.68%.
According to CRI analysis, with the effective alleviation of the Covid-19 epidemic from 2021 to 2025, the sales of Voriconazole will have a restorative growth. In addition, there are 9 companies that have applied to enter the Chinese Voriconazole market in 2020. The price of Voriconazole will decline and the sales and sales volume have the potential for growth with the addition of new manufacturers. In addition, Voriconazole is used for various fungal infections and the number of specific indications is likely to increase, so its sales volume and sales still have the potential for increase.
Topics Covered:
-The impact of COVID-19 on China’s Voriconazole market
– Sales value of China’s Voriconazole 2016-2020
– Competitive landscape of China’s Voriconazole market
– Prices of Voriconazole in China
– Prices of Voriconazole in China by regions and manufacturers
– Analysis of factors affecting the development of China’s Voriconazole market
– Prospect of China’s Voriconazole market from 2021 to 2025
Table of Contents
Table of Contents
1 Relevant Concept of Voriconazole
1.1 Indications for Voriconazole
1.2 Development of Voriconazole in China
1.3 Governmental Approval of Voriconazole in China
1.4 The Impact of COVID-19 on Voriconazole sales in China
2 Sales of Voriconazole in China, 2016-2020
2.1 Sales Value of Voriconazole
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Voriconazole
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Voriconazole by Dosage Form in China, 2016-2020
2.3.1 Oral suspension
2.3.2 Injection
2.3.3 Tablets
2.3.4 Capsules
3 Analysis of Major Voriconazole Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Voriconazole Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Pfizer Europe MA EEIG
3.2.1 Enterprise Profile
3.2.2 Sales of VFEND (Pfizer Europe MA EEIG’s Voriconazole) in China
3.3 Pfizer Ltd
3.3.1 Enterprise Profile
3.3.2 Sales of VFEND (Pfizer Ltd’s Voriconazole) in China
3.4 Sichuan Meidakang Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Huidelikang (Sichuan Meidakang Pharmaceutical Co.,Ltd.’s Voriconazole) in China
3.5 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Furui (Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.’s Voriconazole) in China
3.6 Zhuhai Ebang Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Huibangling (Zhuhai Ebang Pharmaceutical Co.,Ltd.’s Voriconazole) in China
4 Prices of Voriconazole for Different Manufacturers in China, 2020-2021
4.1 Pfizer Europe MA EEIG (VFEND)
4.2 Pfizer Ltd (VFEND)
4.3 Sichuan Meidakang Pharmaceutical Co., Ltd. (Huidelikang)
4.4 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (Furui)
4.5 Zhuhai Ebang Pharmaceutical Co., Ltd.（Huibangling）
5 Prospect of Chinese Voriconazole Market, 2021-2025
5.1 Influential Factors of Chinese Voriconazole Market Development
5.1.1 The Impact of COVID-19 on Chinese Voriconazole Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Voriconazole Oral Suspension Registration in China
Chart Patent Information About Voriconazole Injection Registration in China
Chart Patent Information About Voriconazole Tablets Registration in China
Chart Patent Information About Voriconazole Capsules Registration in China
Chart Sales Value of Voriconazole Oral Suspension over the World
Chart Sales Value of Voriconazole Injection over the World
Chart Sales Value of Voriconazole Tablets over the World
Chart Sales Value of Voriconazole Capsules over the World
Chart Sales Value of Voriconazole Oral Suspension in China, 2016-2020
Chart Sales Value of Voriconazole Injection in China, 2016-2020
Chart Sales Value of Voriconazole Tablets in China, 2016-2020
Chart Sales Value of Voriconazole Capsules in China, 2016-2020
Chart Sales Value of Voriconazole Oral Suspension in China by Regions, 2016-2020
Chart Sales Value of Voriconazole Injection in China by Regions, 2016-2020
Chart Sales Value of Voriconazole Tablets in China by Regions, 2016-2020
Chart Sales Value of Voriconazole Capsules in China by Regions, 2016-2020
Chart Sales Volume of Voriconazole Oral Suspension in China, 2016-2020
Chart Sales Volume of Voriconazole Injection in China, 2016-2020
Chart Sales Volume of Voriconazole Tablets in China, 2016-2020
Chart Sales Volume of Voriconazole Capsules in China, 2016-2020
Chart Sales Volume of Voriconazole Oral Suspension in China by Regions, 2016-2020
Chart Sales Volume of Voriconazole Injection in China by Regions, 2016-2020
Chart Sales Volume of Voriconazole Tablets in China by Regions, 2016-2020
Chart Sales Volume of Voriconazole Capsules in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Voriconazole Oral Suspension Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Voriconazole Injection Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Voriconazole Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Voriconazole Capsules Manufacturers in China, 2016-2020
Chart Sales Value and Volume of VFEND (Pfizer Europe MA EEIG’s Voriconazole) in China, 2016-2020
Chart Sales Value and Volume of VFEND (Pfizer Ltd’s Voriconazole) in China, 2016-2020
Chart Sales Value and Volume of Huidelikang in China, 2016-2020
Chart Sales Value and Volume of Furui in China, 2016-2020
Chart Sales Value and Volume of Huibangling in China, 2016-2020
Chart Referential Prices of VFEND (Pfizer Europe MA EEIG’s Voriconazole) in China by Regions, 2020-2021
Chart Referential Prices of VFEND (Pfizer Ltd’s Voriconazole) in China by Regions, 2020-2021
Chart Referential Prices of Huidelikang in China by Regions, 2020-2021
Chart Referential Prices of Furui in China by Regions, 2020-2021
Chart Referential Prices of Huibangling in China by Regions, 2020-2021
Chart Forecast on Sales Value of Voriconazole Oral Suspension in China, 2021-2025
Chart Forecast on Sales Value of Voriconazole Injection in China, 2021-2025
Chart Forecast on Sales Value of Voriconazole Tablets in China, 2021-2025
Chart Forecast on Sales Value of Voriconazole Capsules in China, 2021-2025
Chart Forecast on Sales Volume of Voriconazole Oral Suspension in China, 2021-2025
Chart Forecast on Sales Volume of Voriconazole Injection in China, 2021-2025
Chart Forecast on Sales Volume of Voriconazole Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Voriconazole Capsules in China, 2021-2025
